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1  | INTRODUC TION
Indoor environments harbor multiple different airborne exposure 
agents capable of entering the human respiratory system. Such 
exposure agents include gaseous pollutants (eg, volatile organic 
compounds (VOCs), nitrate and sulfur compounds, carbon mon-
oxide, carbon dioxide, ozone, and radon), bioaerosols (eg, animal 
dust, pollen, dust-mites, and microbes and their metabolites), and 
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Abstract
In vitro models mimicking the human respiratory system are essential when investi-
gating the toxicological effects of inhaled indoor air particulate matter (PM). We pre-
sent a pulmonary cell culture model for studying indoor air PM toxicity. We exposed 
normal human bronchial epithelial cells, grown on semi-permeable cell culture mem-
branes, to four doses of indoor air PM in the air-liquid interface. We analyzed the 
chemokine interleukin-8 concentration from the cell culture medium, protein con-
centration from the apical wash, measured tissue electrical resistance, and imaged 
airway constructs using light and transmission electron microscopy. We sequenced 
RNA using a targeted RNA toxicology panel for 386 genes associated with toxico-
logical responses. PM was collected from a non-complaint residential environment 
over 1 week. Sample collection was concomitant with monitoring size-segregated 
PM counts and determination of microbial levels and diversity. PM exposure was not 
acutely toxic for the cells, and we observed up-regulation of 34 genes and down-
regulation of 17 genes when compared to blank sampler control exposure. The five 
most up-regulated genes were related to immunotoxicity. Despite indications of in-
complete cell differentiation, this model enabled the comparison of a toxicological 
transcriptome associated with indoor air PM exposure.
K E Y W O R D S
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anthropogenic particles and fibers (eg, vehicle exhaust, combustion 
emissions, house dust, and tobacco smoke). Most of these types of 
inhalation exposure agents have been linked to indoor air problems 
in buildings. Exposure indoors always constitute a combination of 
agents, and it is likely that in many cases, synergistic effects of het-
erogeneous agents instead of a single component are contributing to 
the observed adverse health effects.1 For this reason, measuring the 
combined effects of multiple exposure agents rather than individual 
components is desirable in indoor environmental assessments.
Animal testing has been historically used for studying toxicity 
caused by microbial growth,2 coal combustion derived fine partic-
ulate matter,3 and dust chemicals4 present in the indoor environ-
ment. However, the respiratory system of rodents is anatomically 
and physiologically different from humans.5 Consequently, results 
from animal experiments are not directly comparable with the health 
effects observed in humans. Additionally, 3Rs (ie, replacement, re-
finement, and reduction) legislation and ethical considerations have 
restricted the use of animals in toxicological studies, resulting in re-
placement of in vivo methods with more affordable and easily imple-
mentable in vitro approaches.5 The epithelial layer of the respiratory 
system is the first barrier with which inhaled particles interact within 
the human body. Therefore, new cell culture models in inhalation 
toxicology aim to mimic the human respiratory epithelium.6-8
Human cell culture models are tissue-engineered from either pri-
mary cells (ie, represent the tissue of origin) or secondary cell lines 
(ie, carcinoma-derived or virus-transformed). Co-cultures of different 
secondary cell lines have also been utilized for several years in par-
ticulate matter (PM) exposure studies.6,9 Immortalized secondary cell 
cultures derived from the bronchus and alveolar tissues are relatively 
common in inhalation toxicology. For instance, secondary human 
lung epithelial cells have been used for indoor PM10 toxicity studies
10 
and studying pro-inflammatory responses of spores and hyphae.11 
In secondary cell culture models, different types of cells are co-cul-
tured in either submerged or air-liquid interface (ALI) configurations. 
However, the nature of secondary cell-based systems has changed 
from their original state due to their carcinoid origin or immortaliza-
tion process.12 Moreover, secondary cell line cultures are quite simple 
compared with genuine three-dimensional human lung tissues, which 
consists of more than 40 distinct cell types13 with different functions. 
Consequently, comparing the study results from cell lines to those 
obtained from healthy human lung cells is not straightforward.12
Scientists have highlighted that the use of more complex cell cul-
ture or tissue models would enable us to study cell signaling and in-
teraction in a more realistic way.7,8 In addition to rather complex and 
costly developments such as different micro-tissue chips, for exam-
ple lung-on-a-chip,14 stem cell-derived models,15 and perfused or-
gans,16,17 companies have begun marketing primary cells extracted 
from the human nasal cavity, bronchi, and alveoli after surgical 
procedures or post-mortem. These respiratory primary cells can be 
further differentiated to human airway tissue consisting of multiple 
cell types. For example, in vitro normal human bronchial epithelial 
(NHBE) cell model has been employed for toxicological testing18 and 
for inhalation modeling studies.19 However, human airway construct 
models can be used only once in a single exposure study due to their 
restricted division cycles. These cultures are also relatively expen-
sive and laborious to maintain and differentiate.
The human bronchial epithelium is characterized as being a 
mucociliary phenotype featuring basal, goblet, Clara, ciliated, and 
intermediate cells.18,20-22 Goblet or bronchiolar exocrine cells and se-
cretory ducts protect the respiratory epithelium by forming and se-
creting lung surfactant. Moreover, lung surfactant protects cells via 
mucociliary clearance against inhalable particles and pathogens (eg, 
fungi, bacteria, and viruses). In toxicological studies, lung surfactant 
has been substituted by using water or physiological salt solutions 
containing phospholipids23-25 and surfactants.26,27 In addition, some 
commercially available products, such as Survanta® and Curosurf®, 
have been used.28,29 Synthetic lung lining fluid (LLF) typically consists 
of water, phospholipids, fatty acids, sterols, proteins, and antioxidants 
that have been identified in human-derived lung surfactant.30,31
The aim of our study was to optimize a human airway construct 
model for studying indoor air PM toxicity using synthetic LLF to 
mimic the real human airway exposure more realistically. A commer-
cially available toxicology transcriptome kit for 386 genes associated 
with toxicological responses was utilized for RNA sequencing. These 
measurements were paired with conventional toxicological and mi-
croscopical assessments, as well as with size-resolved monitoring of 
airborne PM and microbial determinations.
2  | MATERIAL S AND METHODS
2.1 | Sampling and monitoring indoor air particulate 
matter
Indoor air particulate matter (PM) samples were collected from a 
non-complaint residential apartment located in an urban area in 
Eastern Finland by using NIOSH BC251 two-stage bioaerosol cy-
clone sampler,32 stage 1, containing particles with cut-off ≥2.1 µm 
in a 15 mL screw cap vial (National Institute for Occupational 
Practical Implications
• Human airway constructs cultured from primary bron-
chial epithelial cells are suitable for studying the toxi-
cological effects of exposure to indoor air particulate 
matter.
• The tested experimental design provided enough high-
quality RNA for transcriptome analysis and showed acti-
vation of particularly immunotoxicological processes by 
indoor air PM.
• This airway epithelial model is a promising tool for com-
paring different indoor environments in environmental 
health research, also because it is well linkable to corre-
sponding microbiome characterization of the exposure.
     |  3NORDBERG Et al.
Safety and Health, NIOSH). An integrated sample was collected 
over the period of 7 days, intermittently for 12 hours each day, 
with total sampling time of 84 hours. The NIOSH sampler was 
operated at 10 L/min. Samples were stored at −20ºC before use. 
Airborne PM for microbial determination was collected using 
Button Inhalable Aerosol Sampler33 (SKC Inc.) onto polytetrafluor-
oethylene (PTFE) filter membranes (pore size 0.45 µm) (Merck 
Millipore) at 4 L/min daily during the same period. Filter samples 
were stored also at −20ºC until processing. Size-resolved (PM2.5 to 
PM10) particle count and estimated mass concentrations (using a 
device-specific assumption of particle mass) were monitored with 
Lighthouse Optical PM3016-IAQ particle counter (Lighthouse 
Worldwide Solutions) during sampling. A proxy of the total parti-
cle mass in the samples was based on the device-derived particle 
mass concentrations in the room air during sampling and the sam-
pled air volume.
2.2 | Sample preparation
2.2.1 | Indoor PM samples
PM samples collected with NIOSH sampler were suspended in cell 
culture medium (DMEM, 10% FBS, 1% Pen-Strep, 1% L-Glut) and 
mixed thoroughly for 30 seconds, sonicated for 15 minutes, and 
mixed again thoroughly for 30 seconds. Airway constructs were ex-
posed to four doses (1:4, 1:8, 1:16, and 1:32) of indoor PM diluted in 
synthetic lung lining fluid (LLF). The estimated total particle mass in 
each of the doses is presented in the results.
2.2.2 | Synthetic lung lining fluid (LLF)
Composition of synthetic LLF is presented in Table 1. All reagents 
used in synthetic LLF were purchased from Sigma-Aldrich.
The recipe for synthetic LLF was adjusted based on previous 
studies.30,34-36 First, non-water-soluble reagents were dissolved in 
acetonitrile (Sigma-Aldrich), albumin, and uric acid in HBSS, and 
rest of the water-soluble reagents in mQ-water. Reagents were 
combined at room temperature and then mixed continuously 
(+37°C) for approximately five hours. After mixing, acetonitrile 
was evaporated under gaseous nitrogen flow in room temperature 
and pH adjusted to 7.25. Synthetic LLF was aliquoted and stored 
in −70°C before use.
2.3 | Culturing human airway constructs
Human airway constructs were cultured and differentiated from 
normal human bronchial epithelial (NHBE) cells (Lonza©). The cells 
were isolated from non-smoking Caucasian 62-year-old male. NHBE 
cells were defrosted and seeded at >3500 cells/cm2 into two T75 
(75 cm2) cell culture flasks. Cells were incubated at 37ºC, 5% CO2 
for 4 days (until 70%-80% confluency). Transparent ThinCert™ cell 
culture inserts (0.336 cm2, pore size 0.4 µm) were treated in 24-well 
plates (Greiner Bio-One®) with 30 µg/mL rat tail collagen (Corning,) 
for 45 minutes before cell seeding. Cells were detached with 0.05% 
trypsin/EDTA solution (Lonza) and then neutralized using trypsin 
neutralizing solution (TNS) (Lonza). Cells were seeded 50 000 cells/
insert and cultured for 3 days. B-ALI™ Basal Media (Lonza) contain-
ing BEGM™ Bronchial Epithelial Cell Growth Medium SingleQuots™ 
Supplements and Growth Factors (Lonza) were changed daily. Cell 
cultures were transferred to air-liquid interface (ALI) in B-ALI™ 
Differentiation Media (Lonza) containing BEGM™ Bronchial Epithelial 
Cell Growth Medium SingleQuots™ Supplements and Growth 
Factors (Lonza) with additional 15 µg/mL retinoic acid (Sigma-
Aldrich), after which the cells were cultured in ALI for 22 days prior 
to exposure. Differentiation medium was renewed every other day. 
Transepithelial electrical resistance (TEER) of the tissue barrier was 
measured using EndOhm chamber and EVOM2™ resistance meter 
(World Precision Instruments), and cell cultures were evaluated using 
light microscope to assess differentiation and wellbeing of the cells.
2.4 | Exposing human airway constructs to 
indoor PM
TEER was measured before exposure experiments and cell cul-
tures with inadequate resistance (≤336 Ohm × cm2) were dis-
carded. Airway constructs were exposed to four doses of indoor 
PM (1:4, 1:8, 1:16, and 1:32) in air-liquid interface (+37°C, 5% 
CO2) for 24 hours. The PM samples were warmed up to +37°C 
and mixed thoroughly for 30 seconds just before applying 50 µL 
of each sample to the cells. 0.1 µg/mL Lipopolysaccharide from 
Escherichia coli O111:B4 (LPS) (Sigma-Aldrich) in LLF was used as 
a positive control.
TA B L E  1   Composition of synthetic LLF. Reagents dissolved in 
acetonitrile indicated with light gray background and water-soluble 
reagents indicated with dark gray background
Reagent
Concentration 
in LLF
1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine 8 mg/mL
Phosphatidylglycerol 1 mg/mL
Phosphatidylethanolamine 0.2 mg/mL
Palmitic Acid 75 µg/mL
Glyceryl Tripalmitate 75 µg/mL
Cholesterol 0.2 mg/mL
α-Tocopherol 1 µg/mL
Albumin Human 0.5 mg/mL
L-Glutathione Reduced 0.5 mg/mL
L-Ascorbic Acid 50 µg/mL
Uric Acid 25 µg/mL
Abbreviation: HBSS, Hank's balanced salt solution.
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2.5 | Analyses and RNA extraction
Transepithelial electrical resistance (TEER) was measured after the 
exposure to assess the integrity of the cell barrier. Chemokine inter-
leukin-8 (IL-8) was analyzed from cell culture medium by using com-
mercially available Human IL-8 DuoSet cytokine kit (R&D Systems) 
and Victor3 plate reader (PerkinElmer) at 570 nm. Furthermore, pro-
tein concentration was analyzed from the apical wash using Bradford 
Reagent (Sigma-Aldrich), 2 mg/mL Protein Standard (Sigma-Aldrich), 
and Victor3 plate reader at 570 nm.
Seven human airway constructs were fixed overnight (2.5% glu-
taraldehyde, 0.1 mol/L phosphate buffer, pH 7.4) for further light 
and transmission electron microscopy (TEM) analysis. RNA was ex-
tracted from 50 human airway constructs using Qiagen RNeasy Plus 
Mini Kit (Qiagen) including DNase treatment. RNA samples were 
stored in −70 ºC and sent on dry ice to Sequencing Unit of Finnish 
Institute for Molecular Medicine (FIMM) for further RNA quality 
control and RNA sequencing.
2.6 | Gene expression profiling by next-generation 
sequencing (NGS)
2.6.1 | RNA quality assessment
Integrity and quantity of RNA was verified by Caliper GX RNA LabChip 
(Perkin Elmer) and Qubit RNA BR system (Thermo Fischer Scientific), 
respectively. Samples with 100 ng of high-quality RNA (RNA score >8, 
DNase treated) were used for expression profiling by RNAseq.
2.6.2 | Library preparation for sequencing
QIAseq Targeted RNA panel Human Molecular Toxicology 
Transcriptome (Qiagen) of 386 genes associated with toxicological re-
sponses was used for first-strand synthesis, molecular barcoding, gene-
specific amplification, sample indexing, and library preparation for 
targeted RNA sequencing according to instructions by manufacturer.
2.6.3 | Sequencing of RNA amplicons
Illumina HiSeq2000 platform was used for sequencing. All the sam-
ples were pooled in one lane of HiSeq flow cell with capacity of 238 
million 100 bp reads.
2.7 | Data analysis
The data were analyzed in GeneGlobe Data Analysis Center. In 
brief, after uploading the RNAseq data in FASTQ format the data 
were trimmed according manufacturer's instructions and aligned 
to GRCh38 reference genome using STAR RNA read mapper. After 
processing the alignments, molecular tags (unique molecular identi-
fiers, UMIs) were counted for 386 genes including gDNA controls, 
reference genes, and a summary of data quality.
For further data analysis, the Secondary QIAseq Targeted RNA 
Panel Data Analysis Software (Qiagen) was used. After data normal-
ization (trimmed mean of M, edgeR)37 and defining the groups for 
comparison, this software analyzed unique molecular index (UMI) 
counts to calculate changes in gene expression. Gene expression 
data were analyzed using Volcano plot analysis with minimum fold 
regulation of two (Student's t test, P < .05).
2.8 | Quantitative and qualitative 
analyses of microbiota
PTFE filter samples collected with Button Inhalable Aerosol sam-
plers were processed as previously described.38 In brief, after an ini-
tial mechanical lysis step on Mini-Beadbeater-16 (Biospec), DNA was 
extracted and purified using Chemagic DNA Plant kit (PerkinElmer, 
Baesweiler) on KingFisher DNA extraction robot (Thermo Scientific). 
Quantitative real-time PCR (qPCR) was performed to assess bacte-
rial and fungal levels in the samples, relying on previously established 
qPCR assays39-42 and following the protocols described earlier.38 
Bacterial PCR targeting the V4 region of the bacterial 16S rRNA 
gene43 (515F/806R) and amplicon sequencing were performed at a 
commercial sequencing partner LGC Genomics (Germany). A detailed 
description of the PCR protocol, amplicon sequencing, and sequence 
processing as performed with minor modifications in this current 
study is provided elsewhere.44 Rather than a nested PCR approach, 
direct PCR without prior pre-amplification was performed for 30 
cycles. Sequencing of a total of 22 samples (including bacterial and 
fungal mock communities, negative controls, and blank controls) was 
done on an Illumina MiSeq with V3 chemistry resulting in paired-end 
reads with a length of 300 bp each. Processing of raw sequences into 
amplicon sequence variants (ASVs) was implemented in the stand-
ard DADA2 pipeline version 1.12.45 Taxonomy was assigned using 
SILVA46 database version 132. Alpha diversity measures, including 
observed ASVs and Chao1, Simpson and Shannon diversity indices, 
as well as taxa summaries were calculated in QIIME (Quantitative 
Insights Into Microbial Ecology)47 software version 1.9.1.
2.9 | Microscopy
Sample preparations and transmission electron microscopy (TEM) 
imaging were undertaken at the SIB Labs (University of Eastern 
Finland, Kuopio, Finland).
2.9.1 | Transmission electron microscopy (TEM)
Samples were pre-fixed with 2.5% glutaraldehyde in 0.1 mol/L 
phosphate buffer (pH 7.4) overnight. After pre-fixing, samples 
     |  5NORDBERG Et al.
were washed with 0.1 mol/L phosphate buffer (pH 7.4) for 20 min-
utes and post-fixed with 1% osmium tetroxide in 0.1 mol/L phos-
phate buffer (pH 7.4) for 1 hour. Samples were washed again with 
0.1 mol/L phosphate buffer (pH 7.4) for 20 minutes and then de-
hydrated gradually with ethanol and infiltrated overnight. Samples 
were polymerized to Laddin LX-112 epoxy resin and cut into ul-
trathin sections (approximately 60-70 nm), and post-stained with 
1% uranyl acetate for 30 minutes and lead citrate for 2 minutes. 
Finally, sections were imaged by using JEOL JEM-2100F HR 
200 kV field emission analytical electron microscope (JEOL Ltd), 
with an attached Olympus Quemesa camera and Olympus iTEM 
software (Olympus).
2.9.2 | Light microscopy (LM)
Semi-thin resin sections of 1.0 µm were cut from TEM blocks and 
stained with toluidine blue.48,49 Samples were imaged using Zeiss 
Axio Imager M2 light microscope (Zeiss), using the 40 × objec-
tive, Carl Zeiss AxioCam MRc high-resolution color camera, and 
Axiovision Rel. 4.8 software (Zeiss).
2.10 | Statistical analyses
Statistical analyses and figures were done using GraphPad Prism 8.1.1 
(GraphPad Software). The normality of the data was tested with the 
Shapiro-Wilk test,50 P < .05. For comparing TEER, chemokine IL-8 
secretion, and protein secretion of exposed airway constructs, con-
trols (LLF, growth medium, and LPS exposed) were compared using 
ordinary one-way ANOVA, Bonferroni's multiple comparisons test,51 
P < .05 and PM exposed cells using two-way ANOVA, Bonferroni's 
multiple comparisons test, P < .05.
3  | RESULTS
3.1 | Particulate matter concentrations and 
microbial content of PM samples
Particle concentrations in indoor air as well as microbial levels and compo-
sition were monitored during individual days of the sampling period. Based 
on the particle count and flow rate, we estimated the total particle mass 
in 7-day integrate indoor PM sample used in the exposure. The estimated 
total particle mass concentration in the highest dose (dilution 1:4) used in 
the exposure experiment was 98 µg/mL, corresponding to a surface load 
of 15 µg/cm2. The mass concentrations of the further dilutions (1:8; 1:16; 
1:32) were estimated to be 49 µg/mL (7.4 µg/cm2), 25 µg/mL (3.7 µg/cm2), 
and 12 µg/mL (1.9 µg/cm2), respectively. The airborne PM concentrations 
(PM2.5 and PM10) showed different diurnal cycles for weekend and work-
ing days, linked to activity patterns in the monitored apartment (Figure 
S1). PM concentrations, and bacterial and fungal levels as well as bacterial 
species richness varied considerably between sampling days (Table S1 and 
Figure S2). This supports the chosen approach to collect and analyze an 
integrated sample of 12-hour sampling periods from seven subsequent 
days. The bacterial content of the 7-day integrated sample was dominated 
by Staphylococcus and other genera that are likely of human origin.
3.2 | Light microscopy and TEM imaging
In light microscopy images, we located two nucleus layers, mucin gran-
ules, and inter-cellular gaps (Figure 1A). In PM exposed cells, we ob-
served loosened inter-cellular gaps between cell layers and signs of 
cytolysis (ie, the dissolution or disruption of cells, especially by an exter-
nal agent) throughout the cell layers following PM exposure (Figure 1B).
In TEM images, the NHBE cell layer was determined to be 12 µm 
thick consisting of two nuclear layers (Figure 2A). Compared with 
control (Figure 2A), we observed multiple signs of cell distress after 
PM exposure (Figure 2B).
Additionally, we observed microvilli, adherens junctions, and 
desmosomes in TEM images (Figure 3). No cilia, basal bodies anchor-
ing cilia, glycocalyx around cilia/microvilli, pseudostratified mor-
phology or maturation of columnar-shaped ciliated and goblet cells 
were visible. We did observe 500 nm long microvilli without basal 
bodies and a 9 + 2 axoneme organization, which are characteristic of 
fully differentiated NHBE tissues (Figure 3).18
3.3 | TEER measurements, protein secretion, and 
chemokine IL-8 secretion
Human airway constructs were secreting surfactant after 10 days 
in air-liquid interface (ALI), which is typical for lung epithelial tissue. 
F I G U R E  1   Toluidine blue-stained semi-
thin sections observed by light microscopy 
(magnifications 400×) of (A) Control and 
(B) indoor air PM exposed (24 h, dose 1:4) 
human airway constructs
(A) (B)
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Tissue resistance reached 360 Ohm × cm2 at Day 14 in ALI and in-
creased up to 1100 Ohm × cm2 at Day 22 (Figure 4).
IL-8 secretion was stimulated after LPS exposure (Figure 5). 
However, chemokine IL-8 production of LLF, growth medium, and LPS 
exposed cells did not differ from each other significantly (ordinary one-
way ANOVA, Bonferroni's multiple comparisons test, P < .05) (Figure 5).
Chemokine IL-8 secretion was consistently, but not statistically 
significantly increased due to PM exposure in different doses com-
pared with control (Figure 6A). NHBE barrier resistance did not sig-
nificantly decrease after indoor PM exposure (Figure 6B) and neither 
did the total protein concentration increase in apical wash after PM 
exposure (Figure 6C).
3.4 | Gene expression profiling
Multiple genes were up- and down-regulated upon PM exposure 
of the cell cultures (Figure 7). There was no statistically significant 
change in transcription of cells when dosed 1:16. Ten genes that 
were significantly up-regulated in cells dosed 1:4 were also up-regu-
lated with 1:8 dosing (Figure 7).
Two most up-regulated genes, ITGAX and LYZ, in 1:8 dosed 
samples were strongly down-regulated in 1:4 dosed samples. 
Transcription of cells dosed to 1:8 PM was most activated, 
F I G U R E  2   Transmission electron microscopy images (magnification 3000×) of human airway constructs exposed 24 h to (A) control and 
(B) indoor air PM (dose 1:4). Microscope JEM-2100F, HV 200 kV and HFW 19.5 µm. Abbreviations: ICJ, inter-cellular junction; Ly, lysosome; 
MV, microvilli; N, nucleus; PL, primary lysosome; PM/NP, particulate matter/nanoparticles; V, vacuole
(A) (B)
F I G U R E  3   Transmission electron microscopy image 
(magnification 12 000×) of human airway construct control. 
Microscope JEM-2100F, HV 200 kV, HFW 4.7 µm. Abbreviations: 
AJ, adherens junction; D, desmosome; ER, rough endoplasmic 
reticulum; MV, microvilli; N, nucleus; R, ribosomes; TJ, tight junction
F I G U R E  4   Mean resistance ± standard deviation (SD) of human 
airway construct barrier after 14 (n = 24), 18 (n = 24), 21 (n = 24), 
and 22 (n = 72) days in air-liquid interface (ALI)
F I G U R E  5   Chemokine IL-8 concentration ± standard deviation 
(SD) after lung lining fluid (LLF) (n = 3), growth medium (n = 3), and 
LPS (n = 3) exposure (24 h)
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F I G U R E  6   (A) Chemokine IL-8 
concentration ± standard deviation 
(SD), (B) Resistance ± SD of the human 
airway construct barrier, and (C) protein 
concentration ± SD in apical wash, 
after indoor PM exposure (n = 3) (24 h) 
compared with control (n = 3). Controls 
indicated with light gray and PM exposure 
with dark gray. Estimated total particle 
mass 15 µg/cm2 (1:4), 7.4 µg/cm2 (1:8), 
3.7 µg/cm2 (1:16), and 1.9 µg/cm2 (1:32)
F I G U R E  7   Heatmap of genes up- 
and down-regulated (fold regulation, 
P < .05, fold difference ≥2) in human 
airway constructs after 24 h of indoor 
PM exposure. Red color indicates up-
regulation and blue color down-regulation. 
Genes that were up- or down-regulated in 
both 1:8 and 1:4 dosed airway constructs 
highlighted with red stars. Dose 1:16 was 
not included due to lack of statistically 
significant differences in transcription. 
Estimated total particle mass 15 µg/cm2 
(1:4), 7.4 µg/cm2 (1:8), 3.7 µg/cm2 (1:16), 
and 1.9 µg/cm2 (1:32)
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up-regulating the expression of 34 genes and down-regulating 17 
genes (fold regulation, P < .05, fold difference ≥2). Up-regulation of 
12 genes was doubled compared with control, and 22 genes were 
even more strongly up-regulated. The number of up- and down-reg-
ulated genes in different cell function categories52 in 1:8 dosed sam-
ples is presented in Figure 8.
Five genes (CD8A, CYP1A1, ITGAX, LYZ, and PTPRC) associated 
with immunotoxicity were among the most up-regulated genes ex-
posed to dose 1:8 indoor PM. Gene expression increased up to 60-
fold compared with control for the most impacted genes in the 1:8 
PM exposure (Table 2). In addition, one oxidative stress-related gene 
(OGG1) was up to eightfold down-regulated compared with control 
(Table 2).
4  | DISCUSSION
When developing new methods for studying indoor PM toxicity, 
multiple factors such as representativeness of sampled PM and used 
in vitro or in vivo models need to be considered. In this study, we 
present a novel approach for assessing indoor PM toxicity, relying 
on measuring transcriptome changes in a panel of genes associated 
in toxicological processes in a human airway construct model. To the 
best of our knowledge, the human airway construct model has not 
been used for elucidating pulmonary toxicity caused by indoor air 
PM exposure before.
Our main aim was to determine whether a human airway con-
struct model could be implemented to observe changes in tran-
scriptome after indoor air PM exposure. For this purpose, PM doses 
adequate for inducing cell activation but not acutely toxic for the 
constructs are required. This was achieved as denoted by (a) acti-
vated secretion of chemokine IL-8, (b) sub-acute toxicity assessed as 
total protein in apical wash, and (c) loss of tissue integrity. The airway 
constructs provided sufficient quantity of high-quality RNA after 
PM exposure, enabling us to sequence RNA by a commercially avail-
able targeted RNA toxicology panel kit. In contrast, the response 
to the Escherichia coli O111:B4 (LPS) used as a positive control, was 
relatively low, suggesting that cultured tissues are less sensitive 
than secondary cell cultures. This is probably due to the presence 
of protective elements such as mucus-producing cells, microvillus, 
and multilayered cells. In future studies, we will aim to test whether 
addition of macrophages in the airway model would increase the 
sensitivity of the model.
After indoor PM exposure, we observed up- and down-regulation 
of multiple genes such as ITGAX, LYZ, PTPRC, CD8A, CYP1A1, and 
OGG1. Strikingly, all five most up-regulated genes were associated 
with immune response. ITGAX, the gene that was most up-regu-
lated, encodes a protein which mediates cell-cell interactions during 
immune reaction and is associated with monocyte adhesion and 
chemotaxis.53 LYZ, another highly up-regulated gene, encodes lyso-
zyme present in tissue fluids and has mainly bacteriolytic function.54 
Interestingly, both of the most up-regulated genes (ITGAX and LYZ) 
in PM exposed cells at the second highest dose level (dose 1:8) were 
the most down-regulated genes at the highest dose level (dose 1:4), 
possibly indicating a feedback mechanism quenching the response 
as the PM dose increases. The most up-regulated genes included 
also tyrosine-protein phosphatase coding PTPRC, which is essential 
in T-cell activation55 and CD8A, which is associated with antigen pro-
cessing and presentation,56 signaling pathways of cell surface recep-
tors,57 differentiation of cytotoxic T cells,57 and immune response.58 
The fifth of the most up-regulated genes, CYP1A1, is associated 
with immunotoxicity52 and xenobiotic metabolism.59 It is also known 
to be up-regulated after exposure to polycyclic aromatic hydrocar-
bons,60 which could be relevant in indoor settings due to exposure 
to indoor combustion particles (eg, from candles or fireplaces) or 
alternatively due to outdoor aerosol infiltration to indoor environ-
ment. In contrast to these five genes, OGG1 was clearly down-regu-
lated. OGG1 is associated with protection against oxidative stress,61 
acute inflammation responses,62 and DNA repair.63 Since PM was 
sampled from a non–moisture-damaged, complaint-free apartment, 
we did not expect to see highly toxic effects on airway constructs. 
Nevertheless, PM exposure induced up- and down-regulation of 
several genes associated with toxicological processes.
Synthetic lung lining fluid was not acutely toxic for airway con-
structs, making it a good candidate for carrier buffer to be used in 
future exposure studies. Arguably, the cells lose their direct contact 
with air during the exposure experiment in our model. However, by 
using synthetic lung lining fluid as a carrier buffer for the PM, we 
can mimic the real-life situation where a film of similar fluid normally 
covers the cells of the airways and the secretion of the mucus is 
further increased during inflammation or irritation. We noted that 
LLF composition and subsequently its effects on airway constructs 
F I G U R E  8   The number of up- and 
down-regulated genes (fold regulation, 
P < .05, fold difference ≥ 2) in different 
cell function categories.52 Airway 
constructs exposed to 1:8 (estimated total 
particle mass 7.4 µg/cm2) indoor PM for 
24 h
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may vary due to challenges in standardizing the LLF preparation pro-
cess. Consequently, we highly recommend testing toxicity of each 
batch before applying synthetic LLF on airway cells. We observed 
also indications that the composition and toxicity may vary due to 
multiple thawing cycles and extended storing even when frozen. 
Without further and detailed testing, maximum of 2 months of stor-
age in −70°C and one thawing cycle is recommended based on our 
observations. Due to long storing and multiple thawing cycles, LLF 
tends to crystallize and form separate phases, therefore becoming 
potentially harmful for the cells.
Light microscopy images indicated that the airway constructs 
were not completely differentiated. When differentiated, pseu-
dostratified airway epithelium should contain tight and adherens 
junctions, desmosomes, different cell types, such as Goblet, ciliated, 
Clara, intermediate and basal cells after 18-30 days in ALI.18,19 In 
pseudostratified airway epithelium, mature cilia (length approxi-
mately 6 µm and width 0.3 µm), longitudinal microtubules inside 
the cilia forming 9 + 2 axoneme arrangement, and microtubules 
emerging from basal bodies are hallmarks of the differentiation 
process.64,65 In this study, we were able to identify tight junctions, 
adherens junctions, desmosomes, microvilli, mucin granules, and 
two cell layers but not fully differentiated structures nor glycoca-
lyx among cilia and microvilli. Interestingly, also free and endoplas-
mic reticulum (ER) bound ribosomes were identified in TEM images, 
which may be due to active protein synthesis following exposure to 
indoor PM. Mucus secretion on Day 10 in ALI and mucin granules 
pictured in light microscopy images likely indicate the presence of 
immature Goblet cells.18,64 Instead of forming a columnar epithe-
lium with pseudostratified morphology, cells formed a stratified 
squamous barrier. The metaplastic squamous differentiation with-
out columnar cell layer was corroborated by light and electron mi-
croscopy. In addition, thickness of the cultures (15-20 µm) indicated 
incomplete differentiation, as fully pseudostratified NHBE cultures 
have been reported to be 40-50 µm thick.18,19 Multiple factors, such 
as collagenization,18 nutrient deficiency, retinoic acid deficiency,66 
temperature, handling, cell count, viability, seeding efficiency, cell 
harvesting protocols, variability between donors,19 cryogenic stor-
age of donor cells, and cell doubling time, may have affected the dif-
ferentiation process.
In this study, we measured transepithelial resistance values of 
1100 Ohm × cm2 in differentiated pulmonary epithelium. Typically, 
fully differentiated NHBE cultures have resistance of 2500-3000 
Ohm × cm2 67 although also significantly lower resistance values of 
600-900 Ohm × cm2 have been reported.19 In commercially avail-
able, readily differentiated NHBE cell cultures TEER values of 500-
600 Ohm × cm2 have been reported.68 Importantly, multiple factors 
such as thickness of the tissue, existence of tight junctions, tempera-
ture, and electrode position affect TEER values. This implies that 
the assessment of the extent of the tissue differentiation cannot be 
based on TEER measurements only, as the reported values vary also 
between fully differentiated constructs.
Transcriptomes of fully differentiated NHBE constructs and 
human airway epithelium in vivo are found to be similar,69 but obtain-
ing fully differentiated constructs remains challenging. When using 
partially differentiated constructs in exposure studies, some factors 
possibly affecting the response to xenobiotic exposure should be 
considered. For example, transcriptional profile70 and microRNA 
expression71 of airway constructs change during differentiation pro-
cess, and fully differentiated airway constructs have been reported 
to have a greater metabolic potential than non-differentiated NHBE 
cells.72 Despite these limitations, non-differentiated NHBE cultures 
have been successfully used for toxicological research.73,74 Although 
not fully differentiated, our human airway constructs demonstrated 
multiple characteristics typical for differentiation and tissue mor-
phology close to normal human airway epithelium. Importantly, we 
showed that the exposed constructs react reproducibly to indoor 
PM, indicating that our model is useful in studying indoor air PM 
toxicity.
The particle count and microbial content of intermittently occu-
pied indoor spaces is known to fluctuate.75,76 Our findings confirm 
the daily variation in the levels of particles and microbes linked to 
activity patterns, which prompted us to use multiple day integrate 
PM samples for toxicity testing. The bacterial content of indoor air 
in the studied apartment was dominated by human associated taxa, 
in line with previous studies showing that human-derived bacteria 
dominate the bacterial content in house dust.77
Aerosol samples can be collected in multiple ways when study-
ing indoor PM including microbial and viral particles.78 Filter-based 
sampling, which requires downstream processing that includes ex-
traction of PM from the filters, may selectively modify the sample 
composition. This is why we believe that our approach to collect the 
samples with cyclone-based, active method into sampling tubes, 
from which particulate matter can be readily resuspended into 
synthetic lung lining fluid, represents inhaled PM in a less modified 
and more realistic way. As a downside of this method, weighing the 
sampled material is not technically feasible, so we had to assess the 
dose-response relationship by testing a series of dilutions of the 
TA B L E  2   Most regulated genes after 1:8 (estimated total 
particle mass 7.4 µg/cm2) PM exposure. Up- and down-regulated 
genes with minimum of fivefold difference in gene expression 
compared with control were included
Gene
Expression compared with 
control (fold regulation)
Cell function 
category52
ITGAX 59 Immunotoxicity
LYZ 42
PTPRC 29
CD8A 11
CYP1A1 6.0
OGG1 −8.0 Oxidative stress and 
DNA damage and 
repair
Abbreviations: CD8A, T-cell surface glycoprotein CD8 alpha chain; 
CYP1A1, cytochrome P450 1A1; ITGAX, integrin alpha-X; LYZ, 
lysozyme C; OGG1, N-glycosylase/DNA lyase; PTPRC, receptor-type 
tyrosine-protein phosphatase C.
10  |     NORDBERG Et al.
collected particulate matter. However, we were able to estimate 
the total particle mass based on the airborne particle count and the 
flow rate during the sampling. Even though this provides only crude 
estimates of the mass concentrations, the levels (12-98 µg/mL) cor-
responded the doses used in earlier studies where cultured alveolar 
epithelial cells were exposed to urban air inhalable PM (25-300 µg/
mL).79
Our study describes the characteristics of indoor PM from one 
apartment, which serves well our aim to test the usefulness of this ex-
perimental model in a real-life situation. However, the choice to ana-
lyze a pre-defined panel of genes of toxicological relevance instead of 
a complete transcriptome limited the scope of conclusions we were 
able to make based on the data. Nevertheless, we are confident that 
the selection of the genes in this panel represents different toxico-
logical pathways well. Moreover, when working with a very limited 
number of samples, a targeted panel is likely a more sound option 
than collecting non-targeted screening data that increase uncertainty 
in data interpretation. The approach presented here will enable us to 
study associations between toxicological responses and microbiota 
characteristics in different types of indoor environments in the fu-
ture. Follow-up of this work will aim at comparing pulmonary toxicity 
caused by indoor PM sampled from multiple non–moisture-damaged 
and moisture-damaged houses (REMEDIAL consortium).
5  | CONCLUSION
Here, we demonstrated that human airway constructs are highly use-
ful in studying indoor air PM toxicity, while our work acknowledges 
that obtaining fully differentiated airway constructs remains chal-
lenging. The studied indoor PM exposure levels, with PM collected 
from a non-complaint residential home, were not acutely toxic for 
airway constructs, but induced up- and down-regulation of several 
genes associated with toxicological responses. Most up-regulated 
genes were related to different functions of immune defense. This 
exposure model enables the comparison of transcriptome related to 
indoor air PM exposures and can be matched with microbiota de-
terminations to study interactions with the toxicological responses.
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